A Mobile App to Improve 24-Hour Movement Guideline Adherence in Preschoolers
University of Kansas Medical Center · with Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · NCT06667661
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 3–4 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 80
- US sites recruiting
- 1
- Study start
- January 29, 2025
- Record last updated
- December 11, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to evaluate whether a home-based mHealth intervention can improve adherence to the 24-Hour Movement Guidelines in preschool-aged children (3-4 years old) who currently meet 0 or 1 of the guidelines for physical activity, sedentary behavior, and sleep. The main questions it aims to answer are:
- Can the intervention increase the proportion of children meeting all three 24-Hour Movement Guidelines (physical activity, screen-time, and sleep)?
- Is the intervention feasible for parents to implement, as measured by a parent feedback survey?
Researchers will compare an intervention group to a waitlist control group to assess whether the intervention leads to increased guideline adherence.
Parents and Participants
- Children will wear an accelerometer to track physical activity and sleep patterns.
- Parents will use a mobile app that delivers weekly lessons and behavior-related goals to encourage healthy movement behaviors in their children.
- Parents will complete questionnaires on their child's movement behaviors and development at baseline, 6 weeks, and 12 weeks.
- Additionally, children will undergo motor skills assessments, and parents will provide feedback on cognitive development and behavioral changes.
Being studied: Shining Star mHealth App
Conditions: Healthy; 24-Hour Movement Guidelines; Feasibility Studies; Sleep; Physical Activity; Screen Time; Sedentary Behaviors; Motor Skills; Cognition; Parent-Child Relations; Mobile Application; Health Education; Child Development
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion (Child):
- Ages 3-4 years.
- Parent report that they meet 0 or 1 recommendation for physical activity, sleep, and screen-time as defined by the 24-hour movement guidelines. The physical activity recommendation is defined as greater than or equal to 3 hours/day of total physical activity, including 1 hour of moderate-to-vigorous physical activity. The sleep recommendation is defined as 10-13 hours/day. The sedentary behavior recommendation is defined as less than or equal to 1 hour/day of sedentary screen-time.
Inclusion (Parents):
- Parents must agree to use their mobile phone for the duration of the study (\~12 weeks) and download the mobile app onto their phone.
- The parent/caregiver is fluent in English to participate in testing the mobile app.
- The parent/caregiver must be willing to travel to KUMC to complete study visits.
Exclusion (child):
- Mobility limitations as reported by the parent.
- Meeting two or more recommendations for physical activity, sleep, and screen-time.
- Sibling or household member is participating or participated in the study.
Recruiting US locations
University of Kansas Medical Center
Kansas City, KS 66160
Site contact: Dr. Chelsea L Kracht, PhD · 913-588-1655 · ckracht@kumc.edu
Study contacts (from the official record)
- Dr. Chelsea L Kracht, PhD · 913-588-1655 · ckracht@kumc.edu
- Jesse D Lyle, MHSA · 785-766-1944 · jlyle5@kumc.edu
Similar studies in Kansas
All sleep studies in Kansas →- RecruitingPhase 2/Phase 3
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Alkermes, Inc.
- Location
- Kansas City, KS + 32 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Alkermes, Inc.
- Location
- Kansas City, KS + 21 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Alkermes, Inc.
- Location
- Kansas City, KS + 21 other US sites
- Eligibility basics
- Ages 18–70